Ryan McLaughlin, Ph.D

From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure

March 14, 2024, 1 PM MST

Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain and behavior. His research has shown that the endocannabinoid system is a vital component of the neuroendocrine and behavioral response to stress, and that pharmacological targeting of this system can be a promising therapeutic strategy for treating stress-related dysfunction. Dr. McLaughlin is a recipient of the Healthy Minds Canada Prize in Children’s Mental Health and his research team is currently funded by federal grants from the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH). He has over 45 peer-reviewed publications in nationally recognized scientific journals, including Biological Psychiatry, Proceedings of the National Academy of Sciences, Journal of Neuroscience, Neuropsychopharmacology, and Pain, and has authored several book chapters detailing the role of the endocannabinoid system in the regulation of stress and emotional behavior. His research has been covered in various news media outlets, including Forbes, Scientific American, The Scientist, The Seattle Times, and The Washington Post.

Previous Webinars

TBA

The next Plant Science and Cultivation Series Webinar will be held in May. Please stay tuned!

Read More »

Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]

Read More »

Roberta Paris, PhD.

Genetic, molecular and biochemical studies on the accumulation of bioactive compounds in Cannabis sativa L.

19 March, 2025, 11:00 AM  

Dr. Roberta Paris studied at the Alma Mater Studiorum, University of Bologna, where she obtained the PhD in Cellular and Molecular Biology in 2006. She is a permanent researcher at Council for Agricultural Research and Economic, Research […]

Read More »

Sarah D. Lichenstein, PhD.

Neural mechanisms of risk for problem-level cannabis use among emerging adults

Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]

Read More »

Kevin Boehnke, PHD.

January 9th at 1:00PM MST

Thoughtful approaches to chronic pain and cannabis research

Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a […]

Read More »

David Gorelick, MD, PHD.

December 12th at 1:00PM MST

Cannabis-related psychiatric disorders

Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]

Read More »